Terms: = Breast cancer AND PER1, O15534, 5187, ENSG00000179094, RIGUI AND Treatment
15 results:
1. Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer.
Sathe C; Accordino MK; DeStephano D; Shah M; Wright JD; Hershman DL
Breast Cancer Res Treat; 2023 Jul; 200(1):85-92. PubMed ID: 37157005
[TBL] [Abstract] [Full Text] [Related]
2. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
3. Disrupting Circadian Rhythm via the per1-HK2 Axis Reverses Trastuzumab Resistance in Gastric cancer.
Wang J; Huang Q; Hu X; Zhang S; Jiang Y; Yao G; Hu K; Xu X; Liang B; Wu Q; Ma Z; Wang Y; Wang C; Wu Z; Rong X; Liao W; Shi M
Cancer Res; 2022 Apr; 82(8):1503-1517. PubMed ID: 35255118
[TBL] [Abstract] [Full Text] [Related]
4. Chronoradiobiology of breast cancer: The Time Is Now to Link Circadian Rhythm and Radiation Biology.
Nelson N; Lombardo J; Matlack L; Smith A; Hines K; Shi W; Simone NL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163264
[TBL] [Abstract] [Full Text] [Related]
5. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
[TBL] [Abstract] [Full Text] [Related]
6. Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?
Peppercorn J; A Carey L
Expert Rev Anticancer Ther; 2008 Feb; 8(2):191-4. PubMed ID: 18279059
[TBL] [Abstract] [Full Text] [Related]
7. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
Ingle JN; Tu D; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Goss PE
Breast Cancer Res Treat; 2006 Oct; 99(3):295-300. PubMed ID: 16541302
[TBL] [Abstract] [Full Text] [Related]
8. Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.
Karnon J; Delea T; Johnston SR; Smith R; Brandman J; Sung J; Goss PE
Pharmacoeconomics; 2006; 24(3):237-50. PubMed ID: 16519546
[TBL] [Abstract] [Full Text] [Related]
9. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL
N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.
Schafer JM; Lee ES; Dardes RC; Bentrem D; O'Regan RM; De Los Reyes A; Jordan VC
Clin Cancer Res; 2001 Aug; 7(8):2505-12. PubMed ID: 11489833
[TBL] [Abstract] [Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract] [Full Text] [Related]
12. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain.
Wolf DM; Jordan VC
Breast Cancer Res Treat; 1994; 31(1):129-38. PubMed ID: 7981453
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice.
Wolf DM; Jordan VC
Breast Cancer Res Treat; 1994; 31(1):117-27. PubMed ID: 7981452
[TBL] [Abstract] [Full Text] [Related]
14. breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue.
Mattia AR; Ferry JA; Harris NL
Am J Surg Pathol; 1993 Jun; 17(6):574-87. PubMed ID: 8333556
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
Gottardis MM; Jiang SY; Jeng MH; Jordan VC
Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
[TBL] [Abstract] [Full Text] [Related]